Pharmakon Inc — Evergreen Park, Illinois

Pharmakon Inc is a clinical research site located in Evergreen Park, Illinois, United States 60805.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Pharmakon Inc has participated in 5 clinical trials.

Therapeutic areas: Irritable Bowel Syndrome With Diarrhea, Pneumococcal Infections, Diabetes Mellitus, Type 2.

Sponsors: Allergan, Merck Sharp & Dohme LLC, Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Evergreen Park

Browse all research sites in Illinois · View every site in Evergreen Park

• Little Company of Mary Hospital
• University of Chicago Medicine Comprehensive Cancer Center
• Little Company of Mary Hospital - Evergreen Park
• University of Chicago
• OSF Little Company of Mary Hospital
• Research by Design
• GSK Investigational Site
• Research Site
• Providea Health Partners
• Fresenius Medical Care of Evergreen Park
• GenHarp Clinical Solutions

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pharmakon Inc?

Pharmakon Inc has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pharmakon Inc conducted?

Pharmakon Inc has 5 clinical trials on record. Their work covers Irritable Bowel Syndrome With Diarrhea, Pneumococcal Infections, Diabetes Mellitus, Type 2.

Is Pharmakon Inc accredited by Crixeo Clinical Trials?

Pharmakon Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pharmakon Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.